- Report
- March 2023
Germany
From €1304EUR$1,500USD£1,135GBP
- Report
- November 2022
- 197 Pages
United States
From €3259EUR$3,750USD£2,836GBP
- Report
- June 2022
- 358 Pages
Global
From €3042EUR$3,500USD£2,647GBP
- Report
- January 2022
- 292 Pages
Global
From €3259EUR$3,750USD£2,836GBP
- Report
- October 2024
- 122 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- August 2024
- 111 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- July 2023
- 200 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- January 2023
- 131 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- March 2024
- 128 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- August 2023
- 141 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- March 2023
- 164 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- December 2024
- 170 Pages
Global
From €5171EUR$5,950USD£4,501GBP
- Report
- August 2023
- 336 Pages
Global
From €2390EUR$2,750USD£2,080GBP
€4780EUR$5,500USD£4,160GBP
- Report
- December 2024
- 61 Pages
Europe
From €2825EUR$3,250USD£2,458GBP
- Report
- December 2024
- 60 Pages
Asia Pacific
From €2825EUR$3,250USD£2,458GBP
- Report
- November 2024
Global
From €4693EUR$5,400USD£4,084GBP
- Report
- November 2024
Global
From €4693EUR$5,400USD£4,084GBP
- Report
- September 2024
- 106 Pages
Global
From €4780EUR$5,500USD£4,160GBP
- Report
- July 2024
- 113 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- February 2024
- 104 Pages
Asia Pacific
From €2564EUR$2,950USD£2,231GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more